Published in Lab Business Week, March 6th, 2005
Highlights for the third quarter of fiscal 2005 include:
1) Quarterly revenues of $12.1 million, compared to previous estimate of $10.5 - $12.0 million.
2) Quarterly fully diluted EPS: $0.04 compared to previous estimate of $0.02 - $0.04 per share.
3) Quarterly U.S. sales of $10.1 million; Quarterly international sales of $2.0 million.
4) Quarterly veterinary sales of $9.9 million, compared to $9.8 million in the...
Want to see the full article?
Welcome to NewsRx!
Learn more about a six-week, no-risk free trial of Lab Business Week